Fibrogen Inc (KYNB) SEC Filings — 2024

Filings

• FibroGen Announces Board and Executive Changes — 8-K · Dec 16, 2024
• Fibrogen Inc SC 13G/A Filing — SC 13G/A · Nov 14, 2024
• Fibrogen Inc SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• Fibrogen Inc SC 13G/A Filing — SC 13G/A · Nov 12, 2024
• FibroGen Reports Q3 2024 Results — 10-Q · Nov 12, 2024
• Fibrogen Inc SC 13G/A Filing — SC 13G/A · Nov 4, 2024
• FibroGen Terminates Material Definitive Agreement — 8-K · Oct 3, 2024
• FibroGen Inc. Faces Delisting Concerns — 8-K · Sep 16, 2024
• FibroGen Announces Executive Compensation Changes — 8-K · Sep 13, 2024
• FibroGen Appoints New Chief Medical Officer — 8-K · Sep 6, 2024
• FibroGen Sells Rimantadine Rights to Eton for $10M — 8-K · Aug 7, 2024
• FibroGen Inc. Q2 2024 Update — 10-Q · Aug 6, 2024
• Fibrogen Inc SC 13G/A Filing — SC 13G/A · Jul 8, 2024
• Fibrogen Inc 8-K Filing — 8-K · Jun 26, 2024
• FibroGen Files 8-K: Shareholder Vote & Financials Update — 8-K · Jun 7, 2024
• FibroGen Inc. Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
• FibroGen Inc. DEF 14A Filing — DEF 14A · Apr 24, 2024
• FibroGen Inc. Files 2023 Annual Report on Form 10-K — 10-K · Feb 26, 2024
• Fibrogen Inc SC 13G Filing — SC 13G · Feb 14, 2024
• Fibrogen Inc SC 13G/A Filing — SC 13G/A · Feb 14, 2024
• Vanguard Trims FibroGen Stake to 5.2%, Holding 4.97M Shares — SC 13G/A · Feb 13, 2024
• PRIMECAP Management Co. Holds 14.47M Shares of FibroGen Stock — SC 13G/A · Feb 12, 2024
• BlackRock Amends FibroGen Stake: Passive Investment Update — SC 13G/A · Jan 26, 2024